MICHAEL SD AGUS, MD
Endowed Chair in Critical Care
Chief, Division of Medical Critical Care
Founding Medical Director, Medical Intensive Care Unit and Intermediate Care Unit
Co-Medical Director, Biocontainment Unit
Boston Children’s Hospital
Professor of Pediatrics, Harvard Medical School
Fellow, American College of Critical Care Medicine
Michael Agus graduated from the Harry B Kellman Academy in 1982 and the Akiba Hebrew Academy in 1986. He received a bachelor’s degree from the University of Pennsylvania in 1990 and an MD degree from the Perelman School of Medicine at the University of Pennsylvania in 1995. He completed his residency training in Pediatrics in
1998, at Boston Children's Hospital and a Fellowship in Pediatric Critical Care Medicine,
at Massachusetts General Hospital in 2002 and a Fellowship in Pediatric Endocrinology at Boston Children's Hospital in 2002.
Dr. Agus is the Division Chief of Medical Critical Care with the Department of Pediatrics at Boston Children’s Hospital where he is the Founding Medical Director of the Medical Intensive Care Unit and the Intermediate Care Unit, and holds an endowed chair in Critical Care. He is also Co-Medical Director of the Biocontainment Unit and is a member of the COVID-19 Leadership Team at Boston Children’s. He is trained and board certified both as a pediatric endocrinologist and pediatric intensivist, and is currently Professor of Pediatrics at Harvard Medical School.
Dr. Agus is engaged in clinical research activities that attempt to address unanswered questions concerning endocrine homeostasis in critically ill children, focusing currently on glycemic control in the ICU. He completed two large NHLBI/NIH R01-funded prospective, randomized clinical trials of glucose control. The first, called SPECS involved 980 post-operative cardiac surgery patients <3 years of age at two centers. The second included 780 medical/surgical patients in 35 Pediatric ICUs across the US and Canada. Results of both trials were published in the New England Journal of Medicine. He used technology, honed over several years of research, to allow the lowest severe hypoglycemia rate in the field. He is currently one of the lead investigators organizing the NICHD/NIH-funded multicenter SHIPSS trial, Stress Hydrocortisone in Pediatric Septic Shock, including Pediatric ICUs across the US and Canada.
Dr. Agus is a recognized teacher and mentor, a Fellow in the American College of Critical Care Medicine, and a member of the honorary societies including Society of Pediatric Research, American Pediatric Society, and American Society for Clinical Investigation. He is the Immediate Past Chair of the Section on Critical Care of the American Academy of Pediatrics.